-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Over time, the Covid-19 epidemic has rapidly evolved, and new virus variants have frequently appeared
Researchers on New Coronary Pneumonia Infection Day compared the clinical results of patients infected with the SARS-CoV-2Delta variant virus in Qatar and those infected with the Beta variant
Researchers use data from the Qatar National COVID-19 database, including data from all individuals who have undergone nucleic acid testing and vaccination information, to identify those infected with the Delta variant and the Beta variant between March 22, 2021 and July 7, 2021
COVID-19
During the study period, a total of 1,427 patients were infected with the Delta variant (252 [55.
Compared with those infected with the Beta variant, those infected with the Delta variant are at higher risk of hospitalization (27.
Differences in clinical outcomes of vaccinated people infected with variant strains
Differences in the clinical outcome of the vaccinated population after being infected with the variant strainIn a cohort study of Covid-19 patients in Qatar, compared with the Beta variant, infection with SARS-CoV-2Delta variants has an increased risk of serious adverse outcomes, and unvaccinated people are more likely to develop severe and critical illness
In the Qatar Covid-19 patient cohort study, compared with the Beta variant, infection with SARS-CoV-2Delta mutation increased the risk of serious adverse outcomes, and the unvaccinated population was more likely to develop severe and critical illness.
Original source:
Adeel A.
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
JAMA
leaves a message here